Related Experiment Video
Updated: Jun 24, 2026

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia
Published on: November 9, 2018
Microglia mediate the clearance of soluble Abeta through fluid phase macropinocytosis
Shweta Mandrekar1, Qingguang Jiang, C Y Daniel Lee
1Alzheimer Research Laboratory, Department of Neurosciences, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106, USA.
Abstract:
Alzheimer's disease is characterized by the progressive deposition of beta-amyloid (Abeta) within the brain parenchyma and its subsequent accumulation into senile plaques. Pathogenesis of the disease is associated with perturbations in Abeta homeostasis and the inefficient clearance of these soluble and insoluble peptides from the brain. Microglia have been reported to mediate the clearance of fibrillar Abeta (fAbeta) through receptor-mediated phagocytosis; however, their participation in clearance of soluble Abeta peptides (sAbeta) is largely unknown. We report that microglia internalize sAbeta from the extracellular milieu through a nonsaturable, fluid phase macropinocytic mechanism that is distinct from phagocytosis and receptor-mediated endocytosis both in vitro and in vivo. The uptake of sAbeta is dependent on both actin and tubulin dynamics and does not involve clathrin assembly, coated vesicles or membrane cholesterol. Upon internalization, fluorescently labeled sAbeta colocalizes to pinocytic vesicles. Microglia rapidly traffic these soluble peptides into late endolysosomal compartments where they are subject to degradation. Additionally, we demonstrate that the uptake of sAbeta and fAbeta occurs largely through distinct mechanisms and upon internalization are segregated into separate subcellular vesicular compartments. Significantly, we found that upon proteolytic degradation of fluorescently labeled sAbeta, the fluorescent chromophore is retained by the microglial cell. These studies identify an important mechanism through which microglial cells participate in the maintenance of Abeta homeostasis, through their capacity to constitutively clear sAbeta peptides from the brain.
Insights
Microglia clear soluble beta-amyloid (sAbeta) via macropinocytosis, a distinct pathway from phagocytosis. This process aids in maintaining brain Abeta homeostasis and peptide degradation.
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Alzheimer's disease involves beta-amyloid (Abeta) deposition and impaired brain clearance.
- Microglia clear fibrillar Abeta (fAbeta) via phagocytosis, but soluble Abeta (sAbeta) clearance is unclear.
Purpose of the Study:
- Investigate microglial mechanisms for clearing soluble Abeta (sAbeta).
- Determine if sAbeta clearance differs from fAbeta clearance.
Main Methods:
- In vitro and in vivo studies using fluorescently labeled sAbeta.
- Analysis of microglial uptake mechanisms (macropinocytosis vs. phagocytosis).
- Microscopic examination of sAbeta localization and degradation within microglia.
Main Results:
- Microglia internalize sAbeta via non-saturable macropinocytosis, distinct from phagocytosis.
- sAbeta uptake depends on actin/tubulin dynamics, not clathrin or cholesterol.
- Internalized sAbeta traffics to late endolysosomes for degradation.
- sAbeta and fAbeta are cleared through separate mechanisms and compartments.
- Degraded sAbeta's fluorescent tag is retained intracellularly.
Conclusions:
- Microglia constitutively clear sAbeta via macropinocytosis, contributing to Abeta homeostasis.
- This mechanism is distinct from fAbeta clearance and involves intracellular degradation.
- Identifies a novel pathway for microglial clearance of soluble amyloid peptides.

